Lataa...

ErbB2 and bone sialoprotein as markers for metastatic osteosarcoma cells

Osteosarcoma is the most common malignant bone neoplasia occurring in young patients in the first two decades of life, and represents 20% of all primitive malignant bone tumours. At present, treatment of metastatic osteosarcoma is unsatisfactory. High-dose chemotherapy followed by CD34+ leukapheresi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Valabrega, G, Fagioli, F, Corso, S, Madon, E, Brach del Prever, A, Biasin, E, Linari, A, Aglietta, M, Giordano, S
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2003
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2747549/
https://ncbi.nlm.nih.gov/pubmed/12569382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600735
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!